The Study
I go through your accounts, contracts and processes. You get a costed plan: how much cost to cut, how much margin to gain, and how fast.
→ Deducted if we partner.
A stake, not an invoice.
Joseph Nahed, operating partner for businesses with €300k to €5M in revenue. I bring the study, the expertise and the tools to cut your costs and grow your profit. I get paid on what I create.
Revenue is there. Profit, much less so. Costs have crept up year after year, subscriptions pile up, some suppliers have never been renegotiated, and you are still the one chasing invoices at night.
A consulting firm will sell you a diagnosis and leave. One more hire will weigh on payroll. What you are missing is a partner who has already run companies with very few people, and who only gets paid if it works.
8 points of cost removed, and profit doubles. That is what the Study goes after, line by line.
And it is deducted if we partner.
I go through your accounts, contracts and processes. You get a costed plan: how much cost to cut, how much margin to gain, and how fast.
→ Deducted if we partner.
I take a minority stake, earned in milestones: a first part at signing, the rest only once lower costs and then higher EBITDA show up in your accounts.
→ No results, no shares.
I carry out the plan with you: renegotiations, processes, pricing, sales, tools. A monthly review of the numbers. You stay in charge.
→ I get paid on the profit I create.
Move the sliders. If your share of a bigger EBITDA beats the EBITDA you take home today, partnering works in your favour.
Indicative simulation, not an offer. The actual stake and milestones are set after the Study, based on your accounts.
AI is a tool, not the point.
Line-by-line review: suppliers, subscriptions, insurance, subcontracting, time spent on work that adds nothing. We cut what earns nothing.
Margin per product and per customer, pricing, collections, sales conversion. The profit is often already there: it leaks between two tools.
I operate 8 companies with no back-office team. AI and automation are my working tools: I put them where they pay, never for show.
I own part of the company: my interest is yours. No 80-page report, no engagement that drags on. An operator's eye on your numbers, every month.
I have run a €5M retail group with 9 stores, turned around a small business before selling my stake, and today I run software used by over a million people. I know what a never-renegotiated supplier costs, a price untouched for three years, a day lost re-typing data.
When I become a partner, I work on your numbers as I do on mine: every month, with you, until the results show up in the accounts.
Joseph Nahed, chairman of NHD
My background →Buying into an existing company, turning it around with its owner, then selling the stake: that is what I did at Symbiose Organisation, long before NHD.
Symbiose Organisation
As a partner alongside its managing director, Eric Ade, I led the turnaround of this €300k-revenue company: back to profit within a year, then 10% growth a year, thanks to key accounts such as Thales, Crédit Agricole, Bouygues, TNT, Filorga and Mappy. I then sold my stake, on a €150k valuation of the company.
NHD turns that approach into a model: the same partner mindset, plus the tools I built to operate my own companies.
symbioseorganisation.fr ↗
With no back-office team. That know-how is what I bring to every company I partner with.
See the portfolioPulse is the platform I run my companies on: client portal, content, acquisition, support, monitoring. Included in what I bring when we partner, available as a subscription otherwise.
Because it aligns our interests. A consultant gets paid whether or not it works. I only earn if your company becomes more valuable. Only the Study is invoiced (€3,000 excl. VAT), and it is deducted if we partner.
Between 10 and 30%, depending on the size of the company and the potential measured by the Study: roughly 20 to 30% between €300k and €1M in revenue, 15 to 20% between €1M and €3M, 10 to 15% between €3M and €5M. It always stays a minority stake, earned in milestones.
The milestones are not reached, and I don't get the corresponding shares. The targets (lower costs, higher EBITDA) are written down before we start and checked against your accounts.
Yes. I am a minority partner; you remain the CEO and the decision-maker. A shareholders' agreement sets governance, information rights, milestones and exit terms. The legal set-up is tailored to each case and reviewed by your advisers.
No. I sell neither services nor automation days. AI is a tool I use to transform the companies I partner with, just like a supplier renegotiation. If you only want a tool, look at Pulse.
One new company every 3 to 6 months, no more. That is what lets me be genuinely present in each one. Applications are reviewed in order of arrival.
Five minutes to apply. Answer within 72 hours. If it fits, we talk for 30 minutes, then start the Study. If not, I tell you why.
Apply